Dr. Michele Zerah Magnino, MD

Dr. Magnino practices at Forefront Dermatology, S.C. in Fairfax, Virginia.

Dr. Magnino's NPI, 1497173512, was assigned on April 5, 2014. Dr. Magnino graduated from Georgetown University School of Medicine in 2014. Dr. Magnino holds Virginia license 0101266253.

Dr. Magnino's primary practice is Forefront Dermatology, S.C., at 3025 Hamaker Ct, Fairfax, VA 22031 in Fairfax County. The practice phone is (703) 442-0300.

Dr. Magnino's primary practice is Forefront Dermatology, S.C. in Fairfax, Virginia. Dr. Magnino is also affiliated with Inova Fairfax Hospital. The medical group on file is Forefront Dermatology. Dmand AI also links Dr. Magnino to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Magnino practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Magnino's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Magnino is licensed in Virginia.

CMS data shows 4,530 Medicare services from Dr. Magnino across 24 procedure codes in 2024, for 949 Medicare patients. Medicare paid $250,442 for them. Every service was in an office.

CMS counts 949 Medicare patients who saw Dr. Magnino in 2024. The largest group is 65 to 74, with 455 patients. 75% of them have high cholesterol, and 62% have high blood pressure. 1% are also on Medicaid. Their average risk score is 0.87, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Magnino's median patient age at 54, with 62% women.

In 2024, Dr. Magnino wrote 1,091 Medicare Part D claims for 378 patients. 82% of them were for generic drugs. CMS names the drug for 885 of them, across 34 drugs with 11 or more claims each, at $566,254 in total drug cost. In 2023, CMS named 369 claims across 16 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Magnino for performance year 2024, reported as part of a group. Dr. Magnino accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,253 procedures of removal of skin lesions by Dr. Magnino, more than 95% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Dr. Magnino, published from 2019 to 2020. Dr. Magnino's most frequent co-authors are Cynthia Marie Carver Deklotz and Scott Alan Norton, MD, MPH.

CMS Open Payments shows 489 general payments to Dr. Magnino from 28 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 41% of the total. Janssen Pharmaceuticals, Inc paid the most, $12,866.

Dr. Magnino graduated from Georgetown University School of Medicine in 2014.